Volume | 1,083,431 |
|
|||||
News | - | ||||||
Day High | 134.67 | Low High |
|||||
Day Low | 133.175 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
iShares Biotechnology ETF | IBB | NASDAQ | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
133.82 | 133.175 | 134.67 | 133.40 | 133.42 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
16,880 | 1,083,431 | 133.60 | 144,743,380 | - | 111.83 - 141.16 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
17:59:56 | 25 | 133.04 | USD |
iShares Biotechnology ETF (IBB) Options Flow Summary
iShares Biotechnology ETF Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
8.28B | 62.10M | - | 58.15M | -92.78M | -1.49 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News iShares Biotechnology ETF
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
IBB Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 132.90 | 134.67 | 131.85 | 133.03 | 1,489,373 | 0.50 | 0.38% |
1 Month | 131.44 | 134.67 | 123.60 | 128.63 | 1,750,167 | 1.96 | 1.49% |
3 Months | 135.93 | 141.16 | 123.60 | 133.92 | 1,749,373 | -2.53 | -1.86% |
6 Months | 115.22 | 141.16 | 113.56 | 132.06 | 1,764,672 | 18.18 | 15.78% |
1 Year | 131.33 | 141.16 | 111.83 | 128.44 | 1,741,952 | 2.07 | 1.58% |
3 Years | 149.85 | 177.37 | 104.29 | 135.90 | 2,096,192 | -16.45 | -10.98% |
5 Years | 104.64 | 177.37 | 92.15 | 132.56 | 2,427,891 | 28.76 | 27.48% |
The fund seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on The NASDAQ Stock Market (NASDAQ). The fund seeks to track the investment results of the NASDAQ Biotechnology Index (the Underlying Index), which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc., including minimum market capitalization and liquidity requirements. |